Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 355

1.

Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C.

Yilmaz Y, Dolar E, Ulukaya E, Akgoz S, Keskin M, Kiyici M, Yerci O, Oral AY, Gul CB, Gurel S, Nak SG, Gulten M.

Med Sci Monit. 2009 Apr;15(4):CR189-93.

PMID:
19333204
[PubMed - indexed for MEDLINE]
2.

Serum apoptotic caspase activity in chronic hepatitis C and nonalcoholic Fatty liver disease.

Papatheodoridis GV, Hadziyannis E, Tsochatzis E, Georgiou A, Kafiri G, Tiniakos DG, Margariti K, Manolakopoulos S, Manesis EK, Archimandritis AJ.

J Clin Gastroenterol. 2010 Apr;44(4):e87-95. doi: 10.1097/MCG.0b013e3181c0945a.

PMID:
19881359
[PubMed - indexed for MEDLINE]
3.

Elevated serum CK18 levels in chronic hepatitis C patients are associated with advanced fibrosis but not steatosis.

Jazwinski AB, Thompson AJ, Clark PJ, Naggie S, Tillmann HL, Patel K.

J Viral Hepat. 2012 Apr;19(4):278-82. doi: 10.1111/j.1365-2893.2011.01546.x. Epub 2011 Nov 24.

PMID:
22404726
[PubMed - indexed for MEDLINE]
4.

Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C.

Giannini E, Botta F, Cataldi A, Tenconi GL, Ceppa P, Barreca T, Testa R.

Hepatogastroenterology. 1999 Jul-Aug;46(28):2422-5.

PMID:
10522010
[PubMed - indexed for MEDLINE]
5.

Circulating cell death products predict clinical outcome of colorectal cancer patients.

Koelink PJ, Lamers CB, Hommes DW, Verspaget HW.

BMC Cancer. 2009 Mar 23;9:88. doi: 10.1186/1471-2407-9-88.

PMID:
19302716
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Correlation of serum adiponectin levels and hepatic steatosis in hepatitis C virus genotype 1 infection.

Kara B, Gunesacar R, Doran F, Kara IO, Akkiz H.

Adv Ther. 2007 Sep-Oct;24(5):972-82.

PMID:
18029322
[PubMed - indexed for MEDLINE]
7.

A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).

Younossi ZM, Jarrar M, Nugent C, Randhawa M, Afendy M, Stepanova M, Rafiq N, Goodman Z, Chandhoke V, Baranova A.

Obes Surg. 2008 Nov;18(11):1430-7. doi: 10.1007/s11695-008-9506-y. Epub 2008 May 24.

PMID:
18500507
[PubMed - indexed for MEDLINE]
8.

Serum iron levels and hepatic iron overload in nonalcoholic steatohepatitis and chronic viral hepatitis.

Uraz S, Aygun C, Sonsuz A, Ozbay G.

Dig Dis Sci. 2005 May;50(5):964-9.

PMID:
15906776
[PubMed - indexed for MEDLINE]
9.

Systematic review: caspase-cleaved fragments of cytokeratin 18 - the promises and challenges of a biomarker for chronic liver disease.

Yilmaz Y.

Aliment Pharmacol Ther. 2009 Dec 1;30(11-12):1103-9. doi: 10.1111/j.1365-2036.2009.04148.x. Epub 2009 Sep 21. Review.

PMID:
19769633
[PubMed - indexed for MEDLINE]
10.

The extent of liver steatosis in chronic hepatitis C virus infection is mirrored by caspase activity in serum.

Seidel N, Volkmann X, Länger F, Flemming P, Manns MP, Schulze-Osthoff K, Bantel H.

Hepatology. 2005 Jul;42(1):113-20.

PMID:
15920717
[PubMed - indexed for MEDLINE]
11.

Serum leptin levels in patients with nonalcoholic steatohepatitis.

Uygun A, Kadayifci A, Yesilova Z, Erdil A, Yaman H, Saka M, Deveci MS, Bagci S, Gulsen M, Karaeren N, Dagalp K.

Am J Gastroenterol. 2000 Dec;95(12):3584-9.

PMID:
11151896
[PubMed - indexed for MEDLINE]
12.

Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.

Papatheodoridis GV, Hadziyannis E, Tsochatzis E, Chrysanthos N, Georgiou A, Kafiri G, Manolakopoulos S, Tiniakos DG, Giannousis I, Manesis EK, Archimandritis AJ.

Gut. 2008 Apr;57(4):500-6. Epub 2007 Nov 19.

PMID:
18025069
[PubMed - indexed for MEDLINE]
13.

Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in children.

Feldstein AE, Alkhouri N, De Vito R, Alisi A, Lopez R, Nobili V.

Am J Gastroenterol. 2013 Sep;108(9):1526-31. doi: 10.1038/ajg.2013.168. Epub 2013 Jun 11.

PMID:
23752877
[PubMed - indexed for MEDLINE]
14.

Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease.

Sumida Y, Nakashima T, Yoh T, Furutani M, Hirohama A, Kakisaka Y, Nakajima Y, Ishikawa H, Mitsuyoshi H, Okanoue T, Kashima K, Nakamura H, Yodoi J.

J Hepatol. 2003 Jan;38(1):32-8.

PMID:
12480557
[PubMed - indexed for MEDLINE]
15.

Serum fragmented cytokeratin 18 levels reflect the histologic activity score of nonalcoholic fatty liver disease more accurately than serum alanine aminotransferase levels.

Tsutsui M, Tanaka N, Kawakubo M, Sheena Y, Horiuchi A, Komatsu M, Nagaya T, Joshita S, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Aoyama T, Tanaka E, Sano K.

J Clin Gastroenterol. 2010 Jul;44(6):440-7. doi: 10.1097/MCG.0b013e3181bdefe2.

PMID:
20104187
[PubMed - indexed for MEDLINE]
16.

Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C.

Kronenberger B, Wagner M, Herrmann E, Mihm U, Piiper A, Sarrazin C, Zeuzem S.

J Viral Hepat. 2005 May;12(3):307-14.

PMID:
15850472
[PubMed - indexed for MEDLINE]
17.

The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease.

Malik R, Chang M, Bhaskar K, Nasser I, Curry M, Schuppan D, Byrnes V, Afdhal N.

J Gastroenterol Hepatol. 2009 Apr;24(4):564-8.

PMID:
19378390
[PubMed - indexed for MEDLINE]
18.

Factors associated with the presence of nonalcoholic steatohepatitis in patients with chronic hepatitis C.

Solis-Herruzo JA, Pérez-Carreras M, Rivas E, Fernández-Vázquez I, Garfia C, Bernardos E, Castellano G, Colina F.

Am J Gastroenterol. 2005 May;100(5):1091-8.

PMID:
15842583
[PubMed - indexed for MEDLINE]
19.

Total and caspase-cleaved cytokeratin 18 in chronic cholecystitis: a prospective study.

Simopoulos C, Tsaroucha AK, Asimakopoulos B, Giatromanolaki A, Gavriilidis P, Polychronidis A, Karayiannakis A.

BMC Gastroenterol. 2008 May 6;8:14. doi: 10.1186/1471-230X-8-14.

PMID:
18460214
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease.

Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, Feldstein AE.

Hepatology. 2006 Jul;44(1):27-33.

PMID:
16799979
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk